Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Acceptability of Treatments and Services for Individuals with Hoarding Behaviors.

Rodriguez CI, Levinson A, Patel SR, Rottier K, Zwerling J, Essock S, Shuer L, Frost RO, Simpson HB.

J Obsessive Compuls Relat Disord. 2016 Oct;11:1-8. doi: 10.1016/j.jocrd.2016.07.001. Epub 2016 Jul 16.

2.

Treatment-refractory anxiety; definition, risk factors, and treatment challenges.

Roy-Byrne P.

Dialogues Clin Neurosci. 2015 Jun;17(2):191-206. Review.

3.

Examining PTSD treatment choice among individuals with subthreshold PTSD.

Bergman HE, Kline AC, Feeny NC, Zoellner LA.

Behav Res Ther. 2015 Oct;73:33-41. doi: 10.1016/j.brat.2015.07.010. Epub 2015 Jul 22.

4.

COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.

Schneier FR, Campeas R, Carcamo J, Glass A, Lewis-Fernandez R, Neria Y, Sanchez-Lacay A, Vermes D, Wall MM.

Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. Epub 2015 Jun 26.

5.
6.

Challenges and Successes in Dissemination of Evidence-Based Treatments for Posttraumatic Stress: Lessons Learned From Prolonged Exposure Therapy for PTSD.

Foa EB, Gillihan SJ, Bryant RA.

Psychol Sci Public Interest. 2013 May;14(2):65-111. doi: 10.1177/1529100612468841.

7.

Prescribing clinicians' perspectives on evidence-based psychotherapy for posttraumatic stress disorder.

Barnett ER, Bernardy NC, Jenkyn AB, Parker LE, Lund BC, Alexander B, Friedman MJ.

Behav Sci (Basel). 2014 Oct 21;4(4):410-22. doi: 10.3390/bs4040410.

8.

Are PTSD treatment choices and treatment beliefs related to depression symptoms and depression-relevant treatment rationales?

Rytwinski NK, Rosoff CB, Feeny NC, Zoellner LA.

Behav Res Ther. 2014 Oct;61:96-104. doi: 10.1016/j.brat.2014.07.013. Epub 2014 Aug 1.

10.

Gender and offender status predicting treatment success in refugees and asylum seekers with PTSD.

Stenmark H, Guzey IC, Elbert T, Holen A.

Eur J Psychotraumatol. 2014 Jan 30;5. doi: 10.3402/ejpt.v5.20803. eCollection 2014.

11.

"How will it help me?" Reasons underlying treatment preferences between sertraline and prolonged exposure in posttraumatic stress disorder.

Chen JA, Keller SM, Zoellner LA, Feeny NC.

J Nerv Ment Dis. 2013 Aug;201(8):691-7. doi: 10.1097/NMD.0b013e31829c50a9.

12.

Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review.

McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW.

J Clin Psychiatry. 2013 Jun;74(6):595-602. doi: 10.4088/JCP.12r07757. Review.

14.

Treatment preference among suicidal and self-injuring women with borderline personality disorder and PTSD.

Harned MS, Tkachuck MA, Youngberg KA.

J Clin Psychol. 2013 Jul;69(7):749-61. doi: 10.1002/jclp.21943. Epub 2013 Feb 26.

15.

The effects of positive patient testimonials on PTSD treatment choice.

Pruitt LD, Zoellner LA, Feeny NC, Caldwell D, Hanson R.

Behav Res Ther. 2012 Dec;50(12):805-13. doi: 10.1016/j.brat.2012.09.007. Epub 2012 Oct 5.

16.

Factors Associated with Choice of Exposure Therapy for PTSD.

Jaeger JA, Echiverri A, Zoellner LA, Post L, Feeny NC.

Int J Behav Consult Ther. 2009;5(3-4):294-310.

17.
18.
19.

Posttraumatic Stress Disorder and Acute Stress Disorder II: Considerations for Treatment and Prevention.

Cahill SP, Pontoski K, D'Olio CM.

Psychiatry (Edgmont). 2005 Sep;2(9):34-46.

20.

Patient preferences for obsessive-compulsive disorder treatment.

Patel SR, Simpson HB.

J Clin Psychiatry. 2010 Nov;71(11):1434-9. doi: 10.4088/JCP.09m05537blu.

Supplemental Content

Support Center